SHAREHOLDERS' EQUITY (Tables)

12 Months Ended

Dec. 31, 2025

SHAREHOLDERS' EQUITY

Summary of information about stock options under the Plan

				Weighted
		Weighted		Average
		Average		Remaining
	Number of	Exercise		Contractual	Intrinsic
	Shares	Price		Life (Years)	Value
	(in thousands, except per share and year data)
Balance at December 31, 2022	448	$	13.43	2.6	$	—
Granted	630		7.22	—		—
Forfeited	(67)		11.45	—		3
Balance at December 31, 2023	1,011	$	9.69	3.0	$	61
Exercised	(8)		7.10	—		6
Forfeited	(75)		10.56	—		49
Expired	(95)		16.70	—		—
Balance at December 31, 2024	833	$	8.84	2.7	$	352
Granted	1,091		10.86	—		—
Exercised	(347)		10.50	—		1,286
Forfeited	(85)		9.94	—		645
Balance at December 31, 2025	1,492	$	9.85	4.0	$	12,925
Exercisable at December 31, 2025	287	$	7.67	2.4	$	3,108

Schedule of weighted-average assumptions used for estimation of the fair value of the options granted under the Plan at the date of grant, using the Black-Scholes Option Valuation Model

		2025	2024		2023
Risk-free interest rate		3.67%	—		4.44%
Dividend yield		0.00%	—		0.00%
Volatility factor of the expected market price of common stock		61%	—		67%
Weighted-average expected life of option		3 years	—		3 years
Weighted-average grant date fair value	$	4.70	—	$	3.36

Summary of status and activity of non-vested stock options

		Weighted Average
		Grant Date
	Number of	Fair Value
	Shares	Per Share
	(in thousands, except per share amounts)
Non-vested balance at December 31, 2024	385	$	3.37
Granted	1,091		4.70
Forfeited	(67)		4.18
Vested	(202)		3.36
Non-vested balance at December 31, 2025	1,207	$	4.53

Schedule of Restricted Stock Units

	Number of Shares
	(in thousands)
Balance at December 31, 2022	—
Granted	109
Vested and issued	(80)
Balance at December 31, 2023	29
Granted	258
Vested and issued	(273)
Balance at December 31, 2024	14
Granted	249
Vested and issued	(175)
Balance at December 31, 2025	88